NYSE: AMRZ

Amrize (AMRZ) Stock Analysis & Forecast

Sep 28 close

$38.05−0.17 (−0.4%)
Add to Watchlist

Gekko Brief

AI summary

Amrize draws mixed analyst attention this week. One piece cites healthy commercial and infrastructure demand and expects Building Envelope margins to recover as price increases offset raw material and freight inflation, with further improvement anticipated in the second half of 2026. Against that, UBS cuts its price target on Amrize to $42 from $57 while maintaining a Neutral rating, and short interest is reported at 9.74 million shares as of 15 September 2026, a 6.00% increase from the prior period, with 1.77% of public float sold short and 2.0 days to cover.

The stock closes at $38.05, down 0.4%, sitting below both its 50-day ($44.65) and 200-day ($52.64) averages, with the shorter average also below the longer one. Returns have been negative across recent stretches, including a 1-month decline of 14.1% and a 6-month decline of 29.3%. The GekkoIndex reads 67.5, placing Amrize in the Accumulation zone, while price sits 32.4% below Gekko Fair Value of $56.32.

Amrize next reports earnings on 27 October 2026, 28 days out and inside a typical 20-trading-day holding window; its prior report on 6 August 2026 missed estimates ($0.88 versus $0.92) and triggered an 11.8% reaction, with an average absolute move of 6.7% across recent quarters. Over the last 90 days, insiders made 14 open-market purchases totaling $2,578,655, alongside 1 congressional buy and no sales. Analyst consensus across 15 firms shows 6 buy, 8 hold, and 1 sell ratings, with a consensus target of $51.79.

Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.

Amrize price vs fair value

$56.32$38.05Sep ’25Mar ’26Sep ’26
Close $38.05200-day averageGekko Fair Value $56.32

Amrize quick facts

Market cap
$21.06B
P/E ratio
17.1
Forward P/E
13.4
EPS, TTM
$2.23
Revenue, TTM
$12.18B
Profit margin
10.1%
Dividend yield
1.18%
Beta
—
Volume
3.70M avg 4.45M
1-year return
−19.7%
Typical daily move
±2.9%
Typical 20-day move
±6.1%
50-day average
$44.65
200-day average
$52.64
Next earnings
Oct 27
Shares outstanding
546.9M
52-week range
$36.87$65.94

Amrize swing-trade checklist

Amrize scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive0 mixed2 headwinds

  • Trendheadwind

    Below 50 and 200-day

    Close $38.05 is below the 50-day ($44.65) and 200-day ($52.64) averages, and the 50-day is below the 200-day.

    See the chart
  • GekkoIndexsupportive

    67.5, Accumulation

    Reading 67.5 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    32.4% below

    Price is 32.4% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneysupportive

    Leans bullish

    Last 90 days: 14 open-market insider purchases; Congress 1 buy / 0 sales.

    See smart money
  • Earnings riskheadwind

    Reports in 28 days

    Reports on Oct 27, 2026, 28 days away — inside a typical 20-trading-day hold.

    See earnings
  • Seasonalityno data

    No data

    Not enough years of history for a seasonal read.

A description of current data, not a recommendation. How this page works

Amrize stock chart and price history

Amrize closed at $38.05 on Sep 28, 2026, −19.7% over the past year, inside a 52-week range of $36.87 to $65.94.

5Y and weekly in Gekko
Close50-day average200-day averageVolume
Amrize share price, past year, with 50-day and 200-day moving averages and volume$40$50$60NovDecJan 2026FebMarAprMayJunJulAugSep38.05

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−14.1%
3 months
−28.4%
6 months
−29.3%
1 year
−19.7%
The full AMRZ chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open AMRZ in Gekko

Follow Amrize through every session

Put AMRZ on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track AMRZ in GekkoFree for 7 days. No credit card required.

Amrize GekkoIndex: the smart money zone

Amrize’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 67.5, in the Accumulation zone, down 3.5 points over five sessions.

010067.5Accumulation

Down 3.5 points over five sessions, from the Buying zone.

Reading for Sep 28, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying18+0.7%+0.6%+7.1%+7.9%
Accumulation (current zone)121+0.5%+0.2%+0.2%−0.4%
Neutral162−1.0%−1.1%−1.9%−2.4%
Distribution12−1.5%−4.6%−9.7%−7.5%
Selling0Not available

Average AMRZ share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the AMRZ price, zone by zone.Track AMRZ in Gekko

Is Amrize stock overvalued? Gekko Fair Value

Amrize trades 32.4% below Gekko Fair Value of $56.32, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Amrize shares are worth, recalculated every trading day.

$56.32

Gekko Fair Value, Sep 29, 2026

32.4% Undervalued

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open AMRZ in Gekko

Amrize insider and Congress trading

Insiders filed 14 open-market purchases in Amrize worth $2.58M, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

$2.58Min 14 open-market purchases

FiledInsiderTypeSharesValue
Sep 3Jenisch Jan Philipp
director, officer: Chairman & CEO		Purchase15,000$638K
Sep 3Jenisch Jan Philipp
director, officer: Chairman & CEO		Purchase10,000$424K
Sep 3Jenisch Jan Philipp
director, officer: Chairman & CEO		Purchase2,000$85K
Sep 3Jenisch Jan Philipp
director, officer: Chairman & CEO		Purchase2,000$85K
Aug 26Singleton Denise R
officer: Chief Legal Officer & Corp Sec		Purchase3,500$154K

From Form 4 filings, dated to when each was filed.

Congress trades last 90 days

1trade disclosed: 1 purchase and 0 sales.

MemberTypeAmountDisclosed
Ro Khanna
House, CA, purchase		Purchase$1,001 - $15,000Sep 7
traded Aug 7

From congressional disclosures, which report amounts as ranges.

Buybacks

Amrize has been buying back its own shares.

Bought back, quarter ended Jun 30, 2026
$178.0M
As a share of market cap
0.85%

From company filings.

Hedge funds and billionaires quarter ended Jun 30

4of the funds Gekko tracks hold AMRZ.

1added2opened1trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko

Amrize earnings: next date and track record

Amrize reports on Oct 27, 2026 (28 days away), and beat the EPS estimate in 0 of its last 8 reports.

0 of 8reports beat the EPS estimate
±6.7%average move across the report
3 of 6reports followed by a gain

Share-price move across each report

−7.1%Aug ’25+6.0%Oct ’25+8.3%Feb ’26−6.4%Apr ’26+0.7%May ’26−11.8%Aug ’26

Last earnings call, Aug 6, 2026 AI summary

What they said
Amrize reported Q2 2026 revenue growth of 8.6% with organic growth of 6.7%, driven by mega project demand in data centers, energy, and infrastructure. Net income grew 14.4%, adjusted EBITDA rose 5.8%, and diluted EPS increased 14.7%. The company invested $241M in CapEx and returned $502M to shareholders via dividends and buybacks. Oil-driven cost inflation impacted freight and materials costs, managed through pricing and the ASPIRE program.
Guidance
Management expects infrastructure demand to remain strong supported by the Infrastructure Act and proposed Build America 250 Act. Residential construction remains soft but seasonal patterns are expected to support roofing stability. Commercial mega project backlog provides consistent long-term demand visibility.
ReportedEPSSurpriseRevenueSurpriseMove
Aug 6, 2026$0.88
est $0.92		−4.3%$3.49B
est $3.37B		+3.8%−11.8%
May 19, 2026−$0.21
est −$0.12		−75.0%$2.18B
est $2.15B		+1.2%+0.7%
Apr 29, 2026−$0.16
est −$0.13		−18.7%$2.18B
est $2.13B		+2.4%−6.4%
Feb 17, 2026$0.54
est $0.65		−16.4%$2.84B
est $2.92B		−2.8%+8.3%
Oct 28, 2025$0.98
est $1.02		−3.9%$3.68B
est $3.49B		+5.4%+6.0%
Aug 6, 2025$0.78
est $1.03		−24.3%$3.22B
est $3.39B		−5.0%−7.1%
Jun 2, 2025−$0.10
est $1.15		−108.7%$2.08B
est $3.39B		−38.6%—
May 7, 2025−$0.14
est −$0.06		−127.5%$2.08B
est $2.08B		0.0%—

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Amrize stock forecast and analyst price targets

Analysts’ average 12-month price target for Amrize is $51.79, +36.1% from the last close, from 15 firms rating the stock in the last 90 days.

$51.79consensus 12-month target, +36.1% from the last close
Low $36.94High $60
Buy6
Hold8
Sell1

Each firm’s latest rating in the last 90 days: 15 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Sep 24BernsteinBuy, maintained$60+57.7%
Sep 23Deutsche Bank Buy, reiterated$56+47.2%
Sep 22JefferiesHold, maintained$36.94−2.9%
Sep 22UBSHold, maintained$42+10.4%
Sep 21Morgan StanleyBuy, maintained$54+41.9%
+0.2%average 20-day move after past Accumulation readings
±2.9%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Amrize market cap and key statistics

Amrize’s market cap is $21.06B, with a P/E ratio of 17.1 and revenue of $12.18B over the last twelve months.

Valuation

Market cap
$21.06B
P/E ratio
17.1
Forward P/E
13.4
EPS, TTM
$2.23
Gekko Fair Value
$56.32

Trading

Volume
3.70M
Avg volume, 20 days
4.45M
52-week high
$65.94
52-week low
$36.87
Shares outstanding
546.9M

Financials

Revenue, TTM
$12.18B
Profit margin
10.1%
Return on equity
9.7%
Quarterly earnings growth, YoY
+14.7%

Risk and income

Typical daily move
±2.9%
Typical 20-day move
±6.1%
Dividend yield
1.18%

Amrize stock news this week

Coverage of Amrize this week reads negative: 0 positive, 1 neutral and 3 negative headlines.

News sentiment negative

Amrize peers

Amrize’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
CRHCRH+0.2%Accumulation29.9% below
VMCVulcan Materials+1.3%Accumulation7.2% below
MLMMartin Marietta Materials+2.0%Accumulation8.0% below
JHXJames Hardie Industries+0.4%Accumulation10.9% below
ACAArcosa0.0%Distribution25.0% above
EXPEagle Materials−2.0%Accumulation7.1% below

A peer links to its own page where one exists.

In the Buying zone today

BACHDPEPNVOSCHWMCD

Reporting earnings this week

CCLKMXAIRUECMUJBL

Popular on Gekko

NVDATSLAMSFTAMZNMETAGOOGL

Amrize stock FAQ

What is Amrize’s market cap?

Amrize’s market cap is $21.06B at the Sep 28, 2026 close of $38.05, with 546.9M shares outstanding. The shares trade on a P/E ratio of 17.1.

What is the Amrize stock forecast?

The consensus analyst 12-month price target for Amrize is $51.79, +36.1% from the last close. Of the 15 firms that rated the stock in the last 90 days, 6 rate it a buy, 8 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.

Is Amrize stock overvalued or undervalued?

On Gekko’s estimate Amrize is undervalued: the Sep 28, 2026 close of $38.05 is 32.4% below Gekko Fair Value of $56.32. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Amrize report earnings next?

Amrize is expected to report on Oct 27, 2026 (28 days away). Analysts expect earnings of $1.08 per share on revenue of $3.84B. Amrize beat the earnings estimate in 0 of its last 8 reports, moving 6.7% on average across the report.

What is Amrize’s 52-week high and low?

Amrize’s 52-week high is $65.94 and its 52-week low is $36.87; it closed at $38.05 on Sep 28, 2026, −19.7% over the past year.

Is Amrize stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and smart money) and 2 as headwinds (trend and earnings risk). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

Built and overseen by Jared Mann

Founder of Gekko.app. Jared has traded stocks and ETFs for more than 20 years and has a financial industry background.

About GekkoHow Gekko’s data worksReport an error

See Amrize the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,380 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.